Content about UBS AG

July 16, 2012

An affiliate of private investment firm TPG will acquire Par Pharmaceutical Cos., the drug maker said Monday.

WOODCLIFF LAKE, N.J. — An affiliate of private investment firm TPG will acquire Par Pharmaceutical Cos., the drug maker said Monday.

Par said it had entered into an agreement to be acquired for $1.9 billion. Par shareholders will receive $50 per share, representing a 37% premium over the company's Friday closing price.

December 5, 2011

Shoppers who were out in full force on Black Friday may not walk retail aisles again until just before Christmas — when retailers are expected to heavily discount merchandise — according to the latest America's Research Group/UBS "Christmas Forecast."

CHARLESTON, S.C. — Shoppers who were out in full force on Black Friday may not walk retail aisles again until just before Christmas — when retailers are expected to heavily discount merchandise — according to the latest America's Research Group/UBS "Christmas Forecast."

December 5, 2011

During Black Friday weekend, people were spending more money during an economy where that nasty word "recession" still is on the back of everyone's tongue. But was foot traffic down during the weekend because of the number of tryptophan-dazed consumers walking the aisles a day early to get the best deals?

WHAT IT MEANS AND WHY IT'S IMPORTANT — During Black Friday weekend, people were spending more money during an economy where that nasty word "recession" still is on the back of everyone's tongue. But was foot traffic down during the weekend because of the number of tryptophan-dazed consumers walking the aisles a day early to get the best deals? Or did consumers forsake the Black Friday shopping madness in exchange for the no lines/free shipping offered on Cyber Monday?

August 2, 2011

In line with its new position as a stand-alone corporation, the former U.S. subsidiary of a Swiss drug maker has appointed a new leader.

MELVILLE, N.Y. — In line with its new position as a stand-alone corporation, the former U.S. subsidiary of a Swiss drug maker has appointed a new leader.

Nycomed US announced that Brian Markison, former chairman and CEO of King Pharmaceuticals, will lead the company as president, CEO and a member of the board. The company also appointed Jeff Bailey as COO and John Golubieski as CFO. Both Bailey and Golubieski also held executive roles at King.

January 27, 2011

The abrupt departure of Shoppers Drug Mart president and CEO Jürgen Schreiber announced Wednesday is expected to negatively impact the company’s stock — many investors bought into Shoppers on the faith that retail maven Schreiber would return Canada’s largest drug retailer to consistent quarter-over-quarter growth.

TORONTO — The abrupt departure of Shoppers Drug Mart president and CEO Jürgen Schreiber announced Wednesday is expected to negatively impact the company’s stock — many investors bought into Shoppers on the faith that retail maven Schreiber would return Canada’s largest drug retailer to consistent quarter-over-quarter growth.

September 22, 2010

There may be a silver lining within Rite Aid's second-quarter results that were released Thursday,...